Zevalin™ Y-90 Unit Dose Pig | Mirion Technologies (Capintec), Inc.
111In-ibritumomab tiuxetan, Zevalin
NM Therapies Radiopharm - NMTCB Flashcards | Quizlet
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma - ScienceDirect
Zevalin
90Y-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma: Observations from 111In-Ibritumomab Pretreatment Imaging | Journal of Nuclear Medicine
Cancers | Free Full-Text | Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels
Schematic representation of 90 Y-labelled Zevalin, consisting of the... | Download Scientific Diagram
Intermediaries/Carriers
ZEVALIN - ibritumomab tiuxetan Acrotech Biopharma LLC ----------
Zevalin(®) (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned? | Semantic Scholar
Reference ID: 3366104
Ibritumomab Tiuxetan (Zevalin) Drug Info
90Y-Ibritumomab Tiuxetan in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma | Journal of Nuclear Medicine Technology
Schematic representation of Zevalin ® targeting a lymphoma B-cell with... | Download Scientific Diagram
![PDF] Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin) treatment in follicular non-Hodgkin's lymphoma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c71bb4cd749fd0c63de7c8b4d97499ea80f4da69/2-Figure1-1.png "PDF] Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin) treatment in follicular non-Hodgkin's lymphoma. | Semantic Scholar")
PDF] Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin) treatment in follicular non-Hodgkin's lymphoma. | Semantic Scholar
Ibritumomab tiuxetan (Zevalin) - Indications, Dosing, Side effects
Zevalin
Ibritumomab - Zevalin® - GlobalRPH
Ibritumomab Tiuxetan (Zevalin) Drug Info
Zevalin™ Y-90 Unit Dose Pig – Gamma Gurus
Retreatment with 90Y-labelled ibritumomab tiuxetan in a patient with follicular lymphoma who had previously responded to treatment - The Lancet Oncology
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial - Biology
The radio-labeled antibody 90 Y-ibritumomab tiuxetan (Zevalin) binds to... | Download Scientific Diagram
